Curcumin potently blocks Kv1.4 potassium channels

Biochemical and Biophysical Research Communications

Volumn 344, Issue 4, 2006, Pages 1161-1165

  Liu, Haiyan ^a   Danthi, Sanjay J ^a   Enyeart, John J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Curcumin; Kv1.4; Potassium channel

Indexed keywords

BERTOSAMIL; CLOFILIUM; CURCUMIN; FLECAINIDE; FLUOXETINE; LANTHANUM; NICKEL; POTASSIUM CHANNEL; QUINIDINE; VERAPAMIL; VOLTAGE GATED POTASSIUM CHANNEL;

ADRENAL CELL; ADRENAL GLAND; ANIMAL CELL; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DEPOLARIZATION; ELECTRIC POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; STEADY STATE;

ADRENAL GLANDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; CATTLE; CELLS, CULTURED; CURCUMIN; INHIBITORY CONCENTRATION 50; KV1.4 POTASSIUM CHANNEL; PATCH-CLAMP TECHNIQUES;

BOS TAURUS; CURCUMA LONGA;

EID: 33646175261     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.020     Document Type: Article

References (35)

1. Shim J.S., Kim J.H., Cho H.Y., Yum Y.N., Kim S.H., Park H.J., Shim B.S., Choi S.H., and Kwon H.J. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem. Biol. 10 (2003) 695-704
2. Choudhuri T., Pal S., Das T., and Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem. 280 (2005) 20059-20068
3. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., and Cole G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280 (2005) 5892-5901
4. Egan M.E., Pearson M., Weiner S.A., Rajendran V., Rubin D., Glockner-Pagel J., Canny S., Du K., Lukacs G.L., and Caplan M.J. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304 (2004) 600-602
5. Zeitlin P. Can curcumin cure cystic fibrosis?. N. Engl. J. Med. 351 (2004) 606-608
6. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 78 (2006) 2081-2087
7. Scapagnini G., Foresti R., Calabrese V., Giuffrida Stella A.M., Green C.J., and Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol. Pharmacol. 61 (2002) 554-561
8. Czarnecki A., Dufy-Barbe L., Huet S., Odessa M.F., and Bresson-Bepoldin L. Potassium channel expression level is dependent on the proliferation state in the GH3 pituitary cell line. Am. J. Physiol. Cell physiol. 284 (2003) C1054-C1064
9. Berger A.L., Randak C.O., Ostedgaard L.S., Karp P.H., Vermeer D.W., and Welsh M.J. Curcumin stimulates cystic fibrosis transmembrane conductance regulator Cl-channel activity. J. Biol. Chem. 280 (2005) 5221-5226
10. Dyer J.L., Khan S.Z., Bilmen J.G., Hawtin S.R., Wheatley M., Javed M.u., and Michelangeli F. Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-triphosphate receptor. Cell Calcium 31 (2002) 45-52
11. + channel whose expression is potently inhibited by ACTH. J. Biol. Chem. 275 (2000) 34640-34649
12. + current in adrenal cortical cells through nonhydrolytic binding. J. Gen. Physiol. 110 (1997) 679-692
13. Hamill O.P., Marty A., Neher E., Sakmann B., and Sigworth F.J. Improved patch clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pfügers Arch. 391 (1981) 85-100
14. Brooks S.P., and Storey K.B. Bound and determined: a computer program for making buffers of defined ion concentrations. Anal. Biochem. 201 (1992) 119-126
15. + current in adrenocortical cells by an A-kinase-independent mechanism requiring ATP hydrolysis. J. Gen. Physiol. 108 (1996) 251-264
16. + current inhibited by ACTH and Angiotensin II in adrenal cortical cells. J. Biol. Chem. 268 No. 12 (1993) 8640-8644
17. + channel in adrenocortical cells is TREK-1. J. Biol. Chem. 277 (2002) 49186-49199
18. B. Hille, Ion Channels of Excitable Membranes, Sinauer Associates, 2001.
19. Hondeghem L.M., and Katzung B.G. Time and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channelsm. Biochem. Biophys. Acta 472 (1977) 373-398
20. Bean B., Cohen C.J., and Tsien R.W. Lidocaine block of cardiac sodium channelsm. J. Gen. Physiol. 81 (1983) 613-642
21. Lujan R., de Cabo de la Vega C., Dominguez del Toro E., Ballesta J.J., Criado M., and Juiz J.M. Immunohistochemical localization of the voltage-gated potassium channel subunit Kv1.4 in the central nervous system of the adult rat. J. Chem. Neuroanat. 26 (2003) 209-224
22. Wymore R.S., Negulescu D., Kinoshita K., Kalman K., Aiyar J., Gutman G.A., and Chandy K.G. Characterization of the transcription unit of mouse Kv1.4, a voltage-gated potassium channel gene. J. Biol. Chem. 271 (1996) 15629-15634
23. Brahmajothi M.V., Campbell D.L., Rasmusson R.L., Morales M.J., Trimmer J.S., Nerbonne J.M., and Strauss H.C. Distinct transient outward potassium current (Ito) phenotypes and distribution of fast-inactivating potassium channel alpha subunits in ferret left ventricular myocytes. J. Gen. Physiol. 113 (1999) 581-600
24. Neher E. Two fast transient current components during voltage clamp on snail neurons. J. Gen. Physiol. 58 (1971) 36-53
25. + channel proteins in rat central neurons. Neuron 9 (1992) 271-284
26. Cooper E.C., Milroy A., Jan Y.N., Jan L.Y., and Lowenstein D.H. Presynaptic localization of Kv1.4-containing A-type potassium channels near excitatory synapses in the hippocampus. J. Neurosci. 18 (1998) 965-974
27. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., and Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001) 2895-2900
28. Vautier F., Belachew S., Chittajallu R., and Gallo V. Shaker-type potassium channel subunits differentially control oligodendrocyte progenitor proliferation. Glia 48 (2004) 337-345
29. Ivanov A., Gerznaich V., Ivnaova S., Denhaese R., Tsymbalyuk O., and Simard J.M. Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle. J. Physiol. 570 (2006) 73-84
30. Cheong A., Bingham A.J., Li J., Kumar B., Sukumar P., Munsch C., Buckley N.J., Neylon C.B., Porter K.E., Beech D.J., and Wood I.C. Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol. Cell 20 (2005) 45-52
31. Zhang H., Zhu B., Yao J.A., and Tseng G.N. Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity. J. Pharmacol. Exp. Ther. 287 (1998) 332-343
32. + channels Kv1.4. Neuroreport 14 (2003) 2451-2455
33. Herrera D., Mamarbachi A., Simoes M., Parent L., Sauve R., Wang Z., and Nattel S. A single residue in the S6 transmembrane domain governs the differential flecainide sensitivity of voltage-gated potassium channels. Mol. Pharmacol. 68 (2005) 305-316
34. + channels, Kv1.2 and Kv1.4. Eur. J. Pharmacol. 281 (1995) 151-159
35. + current. J. Gen. Physiol. 102 (1993) 239-255